Patient perceptions associated with chemotherapy-induced peripheral neuropathy

Clinical Journal of Oncology Nursing

Volumn 14, Issue 3, 2010, Pages

  Tofthagen, Cindy ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; MALE; PERIPHERAL NEUROPATHY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; QUALITY OF LIFE;

EID: 77956223765     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/10.CJON.E22-E28     Document Type: Review

References (21)

1. Almadrones, L., McGuire, D.B., Walczak, J.R., Florio, C.M., & Tian, C. (2004). Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer. Oncology Nursing Forum, 31, 615-623. doi: 10.1188/04.ONF.615-623
2. American Cancer Society. (2008). Cancer facts and figures, 2008. Retrieved from http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf
3. Backonja, M.M. (2003). Defining neuropathic pain. Anesthesia and Analgesia, 97, 785-790. doi: 0.1213/01.ANE.0000062826.70846.8D
4. Bakitas, M.A. (2007). Background noise: The experience of chemotherapy-induced peripheral neuropathy. Nursing Research, 56, 323-331. doi: 10.1097/01.NNR.0000289503.22414.79
5. Bouhassira, D., Attal, N., Fermanian, J., Alchaar, H., Gautron, M., Masquelier, E., Boureau, F. (2004). Development and validation of the Neuropathic Pain Symptom Inventory. Pain, 108, 248-257. doi: 10.1016/j.pain.2003.12.024
6. Dunlap, B., & Paice, J.A. (2006). Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement. Journal of Supportive Oncology, 4, 398-399. Retrieved from http://www.supportiveoncology.net/journal/articles/0408398.pdf
7. Huang, H.Q., Brady, M.F., Cella, D., & Fleming, G. (2007). Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: A gynecologic oncology group study. International Journal of Gynecological Cancer, 17, 387-393. doi: 10.1111/j.1525-1438.2007.00794.x
8. Krause, S.J., & Backonja, M.M. (2003). Development of a neuropathic pain questionnaire. Clinical Journal of Pain, 19, 306-314. doi: 10.1097/00002508-200309000-00004
9. Lenz, E.R., Pugh, L.C., Milligan, R.A., Gift, A., & Suppe, F. (1997). The middle-range theory of unpleasant symptoms: An update. Advances in Nursing Science, 19(3), 14-27. Retrieved from http://www.nursingcenter.com/Library/JournalArticle.asp?Article_ID=100275
10. Lenz, E.R., Suppe, F., Gift, A.G., Pugh, L.C., & Milligan, R.A. (1995). Collaborative development of middle-range nursing theories: Toward a theory of unpleasant symptoms. Advances in Nursing Science, 17(3), 1-13.
11. Mantyh, P.W. (2006). Cancer pain and its impact on diagnosis, survival and quality of life. Nature Reviews Neuroscience, 7, 797-809. doi: 10.1038/nrn1914
12. National Cancer Institute. (n.d). Dictionary of cancer terms: Peripheral neuropathy. Retrieved from http://www.cancer.gov/dictionary/db_alpha.aspx
13. Ostchega, Y., Donohue, M., & Fox, N. (1988). High-dose cisplatin-related peripheral neuropathy. Cancer Nursing, 11, 23-32. doi: 10.1097/00002820-198802000-00005
14. Postma, T.J., Aaronson, N.K., Heimans, J.J., Muller, M.J., Hildebrand, J.G., Delattre, J.Y., EORTC Quality of Life Group. (2005). The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer, 41, 1135-1139. doi: 10.1016/j.ejca.2005.02.012
15. Rasmussen, P.V., Sindrup, S.H., Jensen, T.S., & Bach, F.W. (2004). Symptoms and signs in patients with suspected neuropathic pain. Pain, 110(1-2), 461-469. doi: 10.1016/j.pain.2004.04.034
16. University of Florida Shands Cancer Center. (2009). Numbness and tingling (peripheral neuropathy). Retrieved from http://www.ufscc.ufl.edu/Patient/content.aspx?section=ufscc&id=23151
17. Visovsky, C. (2003). Chemotherapy-induced peripheral neuropathy. Cancer Investigation, 21, 439-451. doi: 10.1081/CNV-120018236
18. Visovsky, C., Collins, M., Abbott, L., Aschenbrenner, J., & Hart, C. (2007). Putting Evidence Into Practice: Evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clinical Journal of Oncology Nursing, 11, 901-913. doi: 10.1188/07.CJON.901-913
19. Wickham, R. (2007). Chemotherapy-induced peripheral neuropathy: A review and implications for oncology nursing practice. Clinical Journal of Oncology Nursing, 11, 361-376. doi: 10.1188/07.CJON.361-376
20. Wilkes, G. (2007). Peripheral neuropathy related to chemotherapy. Seminars in Oncology Nursing, 23, 162-173.
21. Wilkie, D.J., Huang, H.Y., Reilly, N., & Cain, K.C. (2001). Nociceptive and neuropathic pain in patients with lung cancer: A comparison of pain quality descriptors. Journal of Pain and Symptom Management, 22, 899-910. doi: 10.1016/S0885-3924(01)00351-7